GeoVax Labs, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
GOVX$0.14-9.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Exhibit | |
|---|---|
| Number | Description |
| 3.2 | Certificate of Amendment to Certificate of Incorporation filed January 9, 2026 (2) |
| 4.1 | Form of Pre-Funded Warrant, dated February 17, 2026 (3) |
| 4.2 | Form of Series A-1 Common Warrant, dated February 17, 2026 (3) |
| 4.3 | Form of Series A-2 Common Warrant, dated February 17, 2026 (3) |
| 4.4 | Form of Warrant Amendment Agreement, dated February 17, 2026 (3) |
| 4.5 | Form of Common Stock Purchase Warrant, dated March 31, 2026 (4) |
| 4.6 | Form of Common Stock Purchase Warrant, dated May 8, 2026 (5) |
| 10.1 | Securities Purchase Agreement, dated February 12, 2026 (3) |
| 10.2 | Form of Inducement Letter, dated March 31, 2026 (4) |
| 10.3 | Form of Inducement Letter, dated May 7, 2026 (5) |
| 31.1* | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 |
| 31.2* | Certification pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934 |
| 32.1* | Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2* | Certification pursuant to 18 U.S.C. Section 1350, as adopted by Section 906 of the Sarbanes-Oxley Act of 2002 |
| 101.INS | Inline XBRL Instance Document (1) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document (1) |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (1) |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (1) |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (1) |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (1) |
| 104 | Inline XBRL for the cover page of this Quarterly Report on Form 10-Q and included in the Exhibit 101 Inline XBRL Document Set (1) |
| * | Filed herewith |
|---|---|
| ** | Indicates a management contract or compensatory plan or arrangement |
| (1) | These interactive data files shall not be deemed filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, or Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under these sections. |
| (2) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed January 12, 2026. |
| (3) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed February 17, 2026. |
| (4) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed March 31, 2026o |
| (5) | Incorporated by reference from the registrant’s Current Report on Form 8-K filed May 7, 2026o |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this quarterly report on Form 10-Q to be signed on its behalf by the undersigned thereunto duly authorized.
| GEOVAX LABS, INC. | ||
| (Registrant) | ||
| Date: May 14, 2026 | By: | /s/ Mark W. Reynolds |
|---|---|---|
| Mark W. Reynolds | ||
| Chief Financial Officer | ||
| (duly authorized officer and principal financial officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.